Kimball Electronics/$KE
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Kimball Electronics
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
- Ticker
- $KE
- Sector
- Digital Hardware
- Primary listing
- NASDAQ
- Employees
- 5,600
- Headquarters
- Jasper, United States
- Website
- www.kimballelectronics.com
KE Metrics
BasicAdvanced
$462M
22.96
$0.84
1.19
-
Price and volume
Market cap
$462M
Beta
1.19
52-week high
$32.00
52-week low
$19.11
Average daily volume
204K
Financial strength
Current ratio
1.904
Quick ratio
0.991
Long term debt to equity
0.336
Total debt to equity
0.404
Interest coverage (TTM)
5.78%
Profitability
EBITDA (TTM)
95.321
Gross margin (TTM)
8.20%
Net profit margin (TTM)
1.41%
Operating margin (TTM)
3.84%
Effective tax rate (TTM)
58.99%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
3.02%
Return on equity (TTM)
3.54%
Valuation
Price to earnings (TTM)
22.963
Price to revenue (TTM)
0.323
Price to book
0.8
Price to tangible book (TTM)
0.93
Price to free cash flow (TTM)
-69.235
Free cash flow yield (TTM)
-1.44%
Free cash flow per share (TTM)
-0.278
Growth
Revenue change (TTM)
-1.45%
Earnings per share change (TTM)
-12.67%
3-year revenue growth (CAGR)
-7.75%
10-year revenue growth (CAGR)
5.31%
3-year earnings per share growth (CAGR)
-28.22%
10-year earnings per share growth (CAGR)
-1.40%
What the Analysts think about KE
Analyst ratings (Buy, Hold, Sell) for Kimball Electronics stock.
Analyst projections of the future price of Kimball Electronics stock.
Bulls say / Bears say
First-quarter sales rose 7%, with 3% organic growth across all three business lines. Open orders increased 16% to $690 million, and management expects full-year sales at the high end of its guidance range. (U.S. Securities and Exchange Commission)
Medical sales grew 14%, including 9% organic growth, and newly acquired Helvoet adds medical contract-development and manufacturing capabilities. That could strengthen a faster-growing business and broaden Kimball’s revenue mix. (U.S. Securities and Exchange Commission, The Motley Fool)
A new steering programme is ramping in Poland, and management cited further climate-control opportunities. These programme wins could add growth beyond the medical expansion. (The Motley Fool)
Adjusted operating margin fell to 4.3% from 4.8% a year earlier, despite higher sales. Growth spending and the Indianapolis facility ramp are weighing on near-term profitability. (U.S. Securities and Exchange Commission, The Motley Fool)
Operating cash flow was negative in the quarter as inventories rose, while debt increased to $235.7 million from $116.6 million after the Helvoet deal. That leaves less room for error if the recovery or acquisition benefits take longer to arrive. (The Motley Fool)
More than 70% of automotive sales come from steering programmes, while North American demand remains weak amid lower EV volumes. Management also flagged tight electronic-component supply, which could disrupt production or add cost. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.
KE Financial Performance
Revenues and expenses
KE Earnings Performance
Company profitability
Upcoming events
No upcoming events
KE News
AllArticlesVideos
Funds containing KE
Fund name | Fund size | $KE weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.